Evidence map›Paper›PMID 34618556›Full record

ArticleScience (New York, N.Y.)2021

Population-specific neuromodulation prolongs therapeutic benefits of deep brain stimulation.

Teresa A Spix, Shruti Nanivadekar, Noelle Toong, Irene M Kaplow, Brian R Isett, Yazel Goksen, Andreas R Pfenning, Aryn H Gittis

Abstract read
In one paragraph

Article in Science (New York, N.Y.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 87 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
87citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

87 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Surprises From the Basal Ganglia: Stop and Go Have New Meaning.Movement disorders : official journal of the Movement Disorder Society · 2025
    Review
  18. Article
  19. Article
  20. Article

27 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Teresa A SpixDepartment of Biological Sciences, Carnegie Mellon University, Pittsburgh, PA, USA.ORCID 0000-0001-9663-8102
Shruti NanivadekarNeuroscience Institute, Carnegie Mellon University, Pittsburgh, PA, USA.
Noelle ToongNeuroscience Institute, Carnegie Mellon University, Pittsburgh, PA, USA.ORCID 0000-0001-8825-8361
Irene M KaplowNeuroscience Institute, Carnegie Mellon University, Pittsburgh, PA, USA.ORCID 0000-0002-8924-8269
Brian R IsettDepartment of Biological Sciences, Carnegie Mellon University, Pittsburgh, PA, USA.ORCID 0000-0002-1581-0706
Yazel GoksenDepartment of Biological Sciences, Carnegie Mellon University, Pittsburgh, PA, USA.
Andreas R PfenningDepartment of Biological Sciences, Carnegie Mellon University, Pittsburgh, PA, USA.ORCID 0000-0002-3447-9801
Aryn H GittisDepartment of Biological Sciences, Carnegie Mellon University, Pittsburgh, PA, USA.ORCID 0000-0002-3591-5775

Funding

TRAINING PROGRAM FOR MD/PHD STUDENTST32GM008208 · NIGMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI STEINMAN, RICHARD A · 1987 to 2021
$15.4M
DBS Protocols for Long-Lasting Therapeutic Benefit in Mouse and Primate Models of Parkinson's DiseaseR01NS117058 · NINDS · CARNEGIE-MELLON UNIVERSITY · PI GITTIS, ARYN HILARY, TURNER, ROBERT STERLING · 2020 to 2024
$2.8M
DELINEATING CELL-SPECIFIC OUTPUT PATHWAYS OF THE GPe THAT SUPPORT LONG-LASTING BEHAVIORAL RECOVERY IN DOPAMINE DEPLETED MICER01NS104835 · NINDS · CARNEGIE-MELLON UNIVERSITY · PI GITTIS, ARYN HILARY · 2018 to 2022
$1.9M
CIRCUIT MECHANISMS UNDERLYING LONG-LASTING RECOVERY OF MOVEMENT IN DOPAMINE DPELETED MICE INDUCED BY OPTOGENETIC INTERVENTION IN THE GPeR01NS101016 · NINDS · CARNEGIE-MELLON UNIVERSITY · PI GITTIS, ARYN HILARY · 2018 to 2022
$1.7M
NIGMS NIH HHS T32 GM008208NINDS NIH HHS R01 NS101016NINDS NIH HHS R01 NS104835NINDS NIH HHS R01 NS117058
6 · The paper itself

Abstract

Symptoms of neurological diseases emerge through the dysfunction of neural circuits whose diffuse and intertwined architectures pose serious challenges for delivering therapies. Deep brain stimulation (DBS) improves Parkinson’s disease symptoms acutely but does not differentiate between neuronal circuits, and its effects decay rapidly if stimulation is discontinued. Recent findings suggest that optogenetic manipulation of distinct neuronal subpopulations in the external globus pallidus (GPe) provides long-lasting therapeutic effects in dopamine-depleted (DD) mice. We used synaptic differences to excite parvalbumin-expressing GPe neurons and inhibit lim-homeobox-6–expressing GPe neurons simultaneously using brief bursts of electrical stimulation. In DD mice, circuit-inspired DBS provided long-lasting therapeutic benefits that far exceeded those induced by conventional DBS, extending several hours after stimulation. These results establish the feasibility of transforming knowledge of circuit architecture into translatable therapeutic approaches.

Indexed as

AnimalsDeep Brain StimulationDisease Models, AnimalDopamineFemaleGlobus PallidusMaleMiceMice, Inbred C57BLNeuronsOptogeneticsParkinson DiseaseSubthalamic NucleusSynapsesTranscutaneous Electric Nerve StimulationDopamine

Identifiers

PMID34618556
PMCPMC11098594

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.